The Valley Desk

ReviewFrontiers in molecular biosciencesPublished

Biosafety and biohazard considerations of HSV-1-based oncolytic viral immunotherapy

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Thomas Jefferson University Hospital, with Jefferson Health linked by the institution reference. Affiliation source

Publication record

Type
Review
Venue
Frontiers in molecular biosciences
Published
Subject terms
Review; HSV-1; biosafety; Oncolytic Virotherapy; Oncolytic Immunotherapy
PubMed ID
37795219
PubMed Central ID
PMC10546393
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal